You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.
Access MyCepheid
Each day, nearly 4,500 people lose their lives to TB and close to 30,000 people fall ill. ZDoggMD and Dr. Persing discuss the global impact of a fast and accurate TB test that also detects drug resistance in the United States and globally.
It’s a development that the world has been waiting for, for literally decades. It’s something that has the potential of truly revolutionizing the way we deal with TB today.
- Dr. Mario Raviglione Director, Stop TB Department, WHO. As stated in the TB diagnostics conference call hosted by Advocacy to Control TB Internationally on December 7, 2010
Current MTB diagnostics methods require weeks to deliver a definitive result. Delayed result reporting can lead to patients being left untreated or placed on ineffective therapies. If untreated, patients may continue to spread MTB to others in the community increasing the disease burden.
Great challenges face the global community, including United States, with the worldwide re-emergence of TB and increased number of multi-drug resistant (MDR) and emergence of extensively drug-resistant (XDR) TB strains. The need for fast and accurate TB diagnosis with indication for the drug resistance is greater than ever.
Xpert MTB/RIF, on-demand molecular testing — an ideal solution:
Impact on Patient Isolation Pathway*
